FIELD: pharmacology.
SUBSTANCE: solid pharmaceutical granular composition is described. It contains eslicarbazepine acetate and excipients. In this case, at least 90% of the granules of the composition have a particle size of 1200 microns or less and at least 90% of the granules of the composition have a particle size of 90 microns or more and/or at least 50% of the granules of the composition have a particle size of 250 microns or more. These granules have a specific particle size, determined by the method of screening. Also, a method for producing a pharmaceutical granular composition of eslicarbazepine acetate is disclosed.
EFFECT: inventions provide a uniform distribution of the granules with a low number of small and large particles.
68 cl, 5 ex, 5 tbl, 7 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL FORMULATIONS CONTAINING NITROCATECHOL DERIVATIVES, AND METHODS FOR PREPARING THEM | 2010 |
|
RU2550133C2 |
| DOSAGE FORMS FOR ORAL APPLICATION CONTAINING LICARBAZEPINE ACETATE | 2008 |
|
RU2546521C2 |
| PHARMACEUTICAL PREPARATIONS WITH FIXED COMBINATION OF ANALGESIC AND ANTISPASMODIC AGENTS DOSES | 2015 |
|
RU2704613C2 |
| ORAL PHARMACEUTICAL PREPARATION COMPRISING COMPOUND ELICITING ANTI-ULCER EFFECT AND METHOD FOR PREPARING INDICATED PREPARATION | 1998 |
|
RU2207114C2 |
| PHARMACEUTICAL COMPOSITIONS FOR TREATING CEREBROVASCULAR DISORDERS AND METHODS FOR PREPARING THEM | 2012 |
|
RU2559776C2 |
| NEW COMPOSITION OF LAPATINIB AS A SOLID DOSAGE FORM FOR ORAL USE AND A METHOD OF ITS MANUFACTURE | 2019 |
|
RU2821950C2 |
| PRODUCTS SOLUBLE WITHIN MOUTH CAVITY FORMED BY PRESSING AND METHOD OF MANUFACTURE THEREOF | 1995 |
|
RU2147227C1 |
| DRUG BASED ON TETRAMETILTETRAAZOBITSIKLOOKTANDION AND METHOD FOR ITS PRODUCTION | 2012 |
|
RU2611194C2 |
| PHARMACEUTICAL COMPOSITIONS OF RHEIN OR DIACEREIN | 2008 |
|
RU2484816C2 |
| ORALLY DISINTEGRATING TABLET TEMAZEPAM COMPOSITIONS | 2008 |
|
RU2524638C2 |
